Скачать или смотреть Granules India’s Margin Outlook & Capex Plans | Krishna Prasad Chigurupati

U.S. pricing pressure as well as increased cost of raw materials, solvents and logistics remain challenges, CMD Krishna Prasad Chigurupati said on Q1FY23 numbers. Active pharmaceuticals ingredients (API), pharmaceutical formulation intermediates and finished dosages accounted for 23%, 23% and 54% of revenue respectively. “While overall geopolitical environment is far from being normal, we must take these in our stride and execute Granules 2.0 strategy without any flaw. I feel confident when I see the transformation taking place... [and] we continue to grow and demonstrate excellence and differentiation in whatever we do,” he said. Watch the full interview to know more.

#GranulesIndia #GranulesIndiarevenue ##GranulesIndiaCapex
Subscribe To ET Now For Latest Updates On Stocks, Business News, Trading | https://bit.ly/SubscribeToETNow

To Stay Updated Download the Times Now App :-
Android Google Play : https://goo.gl/zJhWjC
Apple App Store : https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Subscribe Now To Our Network Channels:-
Times Now: https://bit.ly/SubscribeToTimesNow
Mirror Now: https://bit.ly/SubscribeToMirrorNow

Pushed via Slike